James Jenkins, MD.
Dr. Jenkins has disclosed that he has stock in Alkermes, Sage Therapeutics, Teva Pharmaceutical Industries, Trevena, and Viatris.
Dr. Aiken has reviewed this article and has found no evidence of bias pertaining to this educational activity.
It may not be perfect, but this study has the best data yet on the controversial link between benzodiazepines and dementia.
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.